Loss of endothelial cell-specific molecule 1 promotes the tumorigenicity and metastasis of prostate cancer cells through regulation of the TIMP-1/MMP-9 expression

Chien-Min Chen; Chu-Liang Lin; Hui-Ling Chiou; Shu-Ching Hsieh; Chia-Liang Lin; Chun-Wen Cheng; Chia-Hung Hung; Jen-Pi Tsai; Yi-Hsien Hsieh

doi:10.18632/oncotarget.14684

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Loss of endothelial cell-specific molecule 1 promotes the tumorigenicity and metastasis of prostate cancer cells through regulation of the TIMP-1/MMP-9 expression

Chien-Min Chen, Chu-Liang Lin, Hui-Ling Chiou, Shu-Ching Hsieh, Chia-Liang Lin, Chun-Wen Cheng, Chia-Hung Hung, Jen-Pi Tsai and Yi-Hsien Hsieh _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:13886-13897. https://doi.org/10.18632/oncotarget.14684

Metrics: PDF 1677 views | HTML 2052 views | ?

Abstract

Chien-Min Chen1,2, Chu-Liang Lin3, Hui-Ling Chiou4, Shu-Ching Hsieh4, Chia-Liang Lin3, Chun-Wen Cheng3, Chia-Hung Hung3, Jen-Pi Tsai5,6, Yi-Hsien Hsieh3,7,8

1Division of Neurosurgery, Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan

2School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

3Institute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung, Taiwan

4School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung, Taiwan

5School of Medicine, Tzu Chi University, Hualien, Taiwan

6Division of Nephrology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan

7Department of Biochemistry, School of Medicine, Chung Shan Medical University, Taichung, Taiwan

8Clinical laboratory, Chung Shan Medical University Hospital, Taichung, Taiwan

Correspondence to:

Jen-Pi Tsai, email: [email protected]

Yi-Hsien Hsieh, email: [email protected]

Keywords: prostate cancer cells, endothelial cell specific molecule 1, tumorigenicity, metastasis, epithelial-mesenchymal transition

Received: August 10, 2016 Accepted: January 04, 2017 Published: January 17, 2017

ABSTRACT

The Endothelial cell specific molecule-1 (ESM1) protein has been involved in proliferation and metastatic progression in multiple tumors. However, there are no studies regarding the mechanism of ESM1 in prostate cancer. We found that ESM1 knockdown in prostate cancer cells resulted in increased cell proliferation and colony formation ability response evidenced by decreased expression of p21 and increased expression of cyclin D1 in prostate cancer cells. Moreover, we revealed that knockdown ESM1 also induced the epithelial-mesenchymal transition (EMT), motility and invasiveness in accordance with the upregulated the MMP-9 expression, while downregulated the TIMP-1 expression. Recombinant human (Rh) TIMP-1 significantly attenuated ESM1-mediated cell migration and invasion. Additionally, ESM1 knockdown increased in vivo tumorigenicity and metastasis of prostate cancer cells. These findings provide the first evidence that the imbalance of MMP-9/TIMP-1, is one of the regulation mechanisms by which ESM1 promotes tumorigenicity and metastasis of prostate cancer cells.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 14684

Publication Alerts

Research Papers:

Loss of endothelial cell-specific molecule 1 promotes the tumorigenicity and metastasis of prostate cancer cells through regulation of the TIMP-1/MMP-9 expression

Abstract